Citation Impact
Citing Papers
Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation
2013 StandoutScience
Review of ultrasound mediated drug delivery for cancer treatment: updates from pre-clinical studies
2014
Synovitis in osteoarthritis: current understanding with therapeutic implications
2017 Standout
ESUR prostate MR guidelines 2012
2012 Standout
Why do cancers have high aerobic glycolysis?
2004 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Phase I Clinical Evaluation of Citrate-coated Monocrystalline Very Small Superparamagnetic Iron Oxide Particles as a New Contrast Medium for Magnetic Resonance Imaging
2004
Gold nanoparticles: a new X-ray contrast agent
2006
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Engineered Magnetic Nanoparticles for Biomedical Applications
2013
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Gum Arabic as a Phytochemical Construct for the Stabilization of Gold Nanoparticles: In Vivo Pharmacokinetics and X‐ray‐Contrast‐Imaging Studies
2007 Standout
Behavioral Disturbance in Dementia
2012
Noninvasive and targeted delivery of therapeutics to the brain using focused ultrasound
2016
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
2019 Standout
Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates
2018
Alzheimer's disease
2011 Standout
Mesostructured Silica for Optical Functionality, Nanomachines, and Drug Delivery
2008 StandoutNobel
Physiological noise in murine solid tumours using T2*-weighted gradient-echo imaging: a marker of tumour acute hypoxia?
2004
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Quantification of Perfusion and Permeability in Multiple Sclerosis
2012
Comparing non-enhanced and enhanced sequences in the assessment of effusion and synovitis in knee OA: associations with clinical, macroscopic and microscopic features
2011
High‐contrast in vivo visualization of microvessels using novel FeCo/GC magnetic nanocrystals
2009
Gadolinium based contrast agents (GBCA): Safety overview after 3 decades of clinical experience
2016
Biomedical applications of biodegradable polymers
2011 Standout
Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders
2018 Standout
Skeletal infections: microbial pathogenesis, immunity and clinical management
2022 Standout
MRI Contrast Enhancement of Necrosis by MP-2269 and Gadophrin-2 in a Rat Model of Liver Infarction
2001
Imaging Atherosclerosis and Vulnerable Plaque
2010
Cytotoxicity of Nanoparticles
2007 Standout
Cardiovascular Magnetic Resonance in Patients With Myocardial Infarction
2009
Preparing Medical Imaging Data for Machine Learning
2020 Standout
The golden age: gold nanoparticles for biomedicine
2011 Standout
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Gadolinium deposition in the brain: summary of evidence and recommendations
2017
19F Magnetic Resonance Imaging (MRI): From Design of Materials to Clinical Applications
2014
Magnetic nanoparticles in MR imaging and drug delivery
2008 Standout
Nanoparticles for Imaging: Top or Flop?
2014
<p>Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics</p>
2019 Standout
Prostate dynamic contrast-enhanced MRI with simple visual diagnostic criteria: is it reasonable?
2006
Safety of the Gadolinium-Based Contrast Agents for Magnetic Resonance Imaging, Focusing in Part on Their Accumulation in the Brain and Especially the Dentate Nucleus
2016
Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity
2007
Recent advances in iron oxide nanocrystal technology for medical imaging☆
2006
Third Universal Definition of Myocardial Infarction
2012 Standout
In Vivo Performance of a Liposomal Vascular Contrast Agent for CT and MR-Based Image Guidance Applications
2007
Liposomes as nanomedical devices
2015 Standout
Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date
2016 Standout
Nanoparticle-based theranostic agents
2010
Cognitive Stimulation in Patients with Dementia: Randomized Controlled Trial
2013 Standout
Breast Cancers: MR Imaging of Folate-Receptor Expression with the Folate-Specific Nanoparticle P1133
2010
Pharmacokinetics and magnetic resonance imaging of biodegradable macromolecular blood‐pool contrast agent PG–Gd in non‐human primates: a pilot study
2011
Nano-magnetite (Fe3O4) as a support for recyclable catalysts in the development of sustainable methodologies
2013 Standout
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Superparamagnetic iron oxide nanoparticles for MR imaging and therapy: design considerations and clinical applications
2014
Pharmacokinetics, Biodistribution and Contrast Enhanced MR Blood Pool Imaging of Gd-DTPA Cystine Copolymers and Gd-DTPA Cystine Diethyl Ester Copolymers in a Rat Model
2006
Management of agitation and aggression associated with Alzheimer disease
2009
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Clearance Properties of Nano-Sized Particles and Molecules as Imaging Agents: Considerations and Caveats
2008 Standout
Targeted nanoparticles for the non-invasive detection of traumatic brain injury by optical imaging and fluorine magnetic resonance imaging
2016
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Rare earth elements: A review of applications, occurrence, exploration, analysis, recycling, and environmental impact
2019 Standout
Multifunctional Inorganic Nanoparticles for Imaging, Targeting, and Drug Delivery
2008 Standout
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Graphene-Like Two-Dimensional Materials
2013 Standout
Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI
2015
Enhancing the Efficacy of Drug-loaded Nanocarriers against Brain Tumors by Targeted Radiation Therapy
2013
Single-nanometer iron oxide nanoparticles as tissue-permeable MRI contrast agents
2021 StandoutNobel
Genetic reduction of Nrf2 exacerbates cognitive deficits in a mouse model of Alzheimer’s disease
2017
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Preclinical models of vertebral osteomyelitis and associated infections: Current models and recommendations for study design
2021
Carbon Nanomaterials for Biological Imaging and Nanomedicinal Therapy
2015 Standout
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Superfluorinated PEI Derivative Coupled with 99mTc for ASGPR Targeted 19F MRI/SPECT/PA Tri‐Modality Imaging
2016
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Nanotechnology for Alzheimer Disease
2017
Superparamagnetic Iron Oxide Nanoparticles: Diagnostic Magnetic Resonance Imaging and Potential Therapeutic Applications in Neurooncology and Central Nervous System Inflammatory Pathologies, a Review
2009
Deep learning enables reduced gadolinium dose for contrast‐enhanced brain MRI
2018
In Vivo Imaging of Carbon Nanotube Biodistribution Using Magnetic Resonance Imaging
2009
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Malonamide-Functionalized Gold Nanoparticles for Selective, Colorimetric Sensing of Trivalent Lanthanide Ions
2009
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
2017 StandoutNobel
Near-infrared fluorophores for biomedical imaging
2017 Standout
Emerging applications for ferumoxytol as a contrast agent in MRI
2014
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers
2018
Calcium phosphates in biomedical applications: materials for the future?
2015 Standout
Works of Philippe Robert being referenced
Ferumoxtran-10 enhancement in orthotopic xenograft models of human brain tumors: an indirect marker of tumor proliferation?
2007
Monitoring Blood-Brain Barrier Status in a Rat Model of Glioma Receiving Therapy: Dual Injection of Low-Molecular-Weight and Macromolecular MR Contrast Media
2010
Magnetic susceptibility matching at the air–tissue interface in rat lung by using a superparamagnetic intravascular contrast agent: Influence on transverse relaxation time of hyperpolarized helium‐3
2005
Pharmacokinetics of Three Gadolinium Chelates with Different Molecular Sizes Shortly After Intravenous Injection in Rabbits
2000
19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticles
2012
T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats
2015
Reduced capillary perfusion and permeability in human tumour xenografts treated with the VEGF signalling inhibitor ZD4190: an in vivo assessment using dynamic MR imaging and macromolecular contrast media
2003
Discrimination of Myocardial Acute and Chronic (Scar) Infarctions on Delayed Contrast Enhanced Magnetic Resonance Imaging With Intravascular Magnetic Resonance Contrast Media
2006
Tumor imaging using P866, a high‐relaxivity gadolinium chelate designed for folate receptor targeting
2008
Septic Arthritis: Monitoring with USPIO-enhanced Macrophage MR Imaging
2011
Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats
2015
P03277—A New Approach to Achieve High-Contrast Enhancement
2015
MR imaging assessment of the kinetics of P846, a new gadolinium‐based MR contrast medium, in ischemically injured myocardium
2008
Evaluation of the Impact of Memantine Treatment Initiation on Psychotropics Use: A Study from the French National Health Care Database
2008
New model for analysis of dynamic contrast‐enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors
2004
Influence of Genetic Background on Apathy-Like Behavior in Triple Transgenic AD Mice
2016
Macrophage Activity in Infected Areas of an Experimental Vertebral Osteomyelitis Model: USPIO-enhanced MR Imaging—Feasibility Study
2008
Improved MR Coronary Angiography with Use of a New Rapid Clearance Blood Pool Contrast Agent in Pigs
2003
How to Compare the Efficiency of Albumin-Bound and Nonalbumin-Bound Contrast Agents In Vivo
2005
Comprehensive model for simultaneous MRI determination of perfusion and permeability using a blood-pool agent in rats rhabdomyosarcoma
2005
Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide
2006
Macrophage imaging by USPIO-enhanced MR for the differentiation of infectious osteomyelitis and aseptic vertebral inflammation
2009
MRI of Macrophages in Infectious Knee Synovitis
2010
Quantitative dynamic contrast enhanced MRI of experimental synovitis in the rabbit knee: Comparison of macromolecular blood pool agents vs. Gadolinium-DOTA
2008
High sensitivity 19F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleen
2011
Dynamic Study of Blood–Brain Barrier Closure after its Disruption using Ultrasound: A Quantitative Analysis
2012
Detection of vascular cell adhesion molecule‐1 expression with USPIO‐enhanced molecular MRI in a mouse model of cerebral ischemia
2012
Comparison of Different Types of Blood Pool Agents (P792, MS325, USPIO) in a Rabbit MR Angiography-like Protocol
2003
Preclinical Profile of the Monodisperse Iodinated Macromolecular Blood Pool Agent P743
2001